BioCrossroads is excited to announce the annual Indiana Life Sciences Summit, scheduled for November 7, 2024, at the Biltwell Event Center in Indianapolis. The Summit will focus on "Transforming Healthcare: Indiana’s Role in Revolutionizing Diabetes and Obesity Management,” highlighting Indiana's significant impact on healthcare, particularly in the development of GLP-1 therapies, which are revolutionizing diabetes and obesity care, and the opportunities that lie ahead for continued advancement of future therapies.
GLP-1 therapies, developed and delivered through the relentless efforts of Indiana's researchers and companies, have emerged as vital tools in managing obesity and diabetes, offering new hope to millions worldwide.
Nationwide, more than 38 million1 Americans are living with diabetes, with obesity being linked to as many as 53 percent of new cases of type 2 diabetes each year.2 In Indiana, more than 12% of the adult population is living with diabetes, with an estimated 31,200 more adults expected to be diagnosed every year,3 and Indiana’s obesity rate is higher than the national average and has been increasing steadily over the past 20
years. As of 2021, 36.3 percent, more than two-thirds of adults in Indiana were obese and 33.3% were overweight. This places Indiana 12th in the nation for obesity4—making the demand for effective solutions even more critical.
"Indiana’s contributions to GLP-1 therapies are also setting new standards in the global fight against obesity and metabolic diseases," said Vince Wong, CEO of BioCrossroads. “The 2024 Indiana Life Sciences Summit is a compelling platform to highlight the pivotal role Indiana has played in bringing transformative innovation to address some of the most challenging unmet needs in healthcare and to gain insights into future developments that will benefit patients, not only in Indiana, but throughout the world. By bringing together industry leaders, researchers, and patients, we aim to foster collaboration and inspire further breakthroughs in diabetes and obesity care.”
A highlight of the event will be the presentation of the prestigious August M. Watanabe Life Sciences Champion of the Year Award, honoring exceptional contributions to life sciences in Indiana. Named in memory of Dr. August "Gus" Watanabe, a visionary in the industry, this award recognizes outstanding achievements and significant contributions in life sciences.
Secure your front row seat for this impactful discussion. Register now and join BioCrossroads at the 2024 Indiana Life Sciences Summit. For more information and to register, please visit BioCrossroads.
